New Rules Require New Solutions
Healthcare and insurance professionals are under extreme pressure to comply with sharps safety legislation. Recent rulings, current legislation and industry advisories all point to the adoption of technologies that prevent the spread of disease and infection.
Compliance Is Step One
The SafeShot Epiphany™ syringe is fully compliant with governing legislation:
- The Needlestick Safety and Prevention Act requires healthcare facilities to maintain, and annually update information on available technology designed to eliminate or minimize exposure to blood borne pathogens.
- The Occupational Safety and Health Administration (OSHA) revised its Blood Borne Pathogen Standard to require more stringent practices to reduce needlestick injuries and to better track their occurrence.
- EU legislation - In July of 2006, similar Legislation was passed in the EU that continues to be refined with more stringent regulations to protect European healthcare workers from blood-borne infections caused by needlestick injuries.
The Epiphany™ Syringe Goes a Step Further:
The SafeShot Epiphany™ syringe is based on unique engineering and vacuum-based technology that remedies the present objections to spring-based technologies, which include: blood splatter, increased costs, device failure, additional steps to activate and tissue trauma upon activation.
SafeShot Has Virtually Eliminated Litigation Risk:
The use of a patented vacuum technology protects SafeShot Technologies from current spring retractable litigation. Syringe manufacturers will spend hundreds of millions in litigation this decade defending their use of a spring for a retraction force.